Enteric Coated Aspirin
- Product NDC
- 49483-331
- 11-digit product format
- 494830331
- Labeler code
- 49483
- Product ID
- 49483-331_2d9d52a2-747c-1f7f-e063-6394a90aa794
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspirin
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Time-Cap Labs, Inc
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2011-01-04
- Substance
- ASPIRIN
- Active strength
- 325 mg/3251
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49483-331-10 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49483-331-01 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49483-331-00 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49483-331-10 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49483-331-01 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49483-331-00 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 49483-331-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 49483-331-01 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 49483-331-00 | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Enteric Coated Aspirin
- Brand name suffix
- Regular Strength
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 325 mg/3251 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R16CO5Y76E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 198467 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5fbd8bb3-46f9-4089-9a21-b6af97a06106 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d7724692-1155-4cc8-a415-22f5fc4aec35 | Product name | 6 | 20220216 |
| bde672ba-4805-28d0-1986-73543d41b412 | Product name | 2 | 20210201 |
| f212291f-05fe-9603-fc7e-bd73e38ce1e6 | Product name | 2 | 20161129 |
| ade821ba-260a-47e2-bd89-743e27ac9906 | Product name | 1 | 20161121 |
| 182f9ab4-4ab5-c449-200f-87ce2ce8e550 | Product name | 2 | 20151105 |
| 9425d234-4ae1-4b53-adc6-8cc7af6dd657 | Product name | 1 | 20150929 |
| 2a21311a-89e2-0e83-2ebd-117f9798b2b2 | Product name | 1 | 20140508 |
| 9007e8a7-ff50-f9b9-7945-f2a1deadd94e | Product name | 1 | 20140508 |
| 96c2be53-8e44-452d-56a2-d255b2f1af2d | Product name | 1 | 20140508 |
| bf8bd5f7-495f-4022-2780-7ded7ea7ea44 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 49483-331-00 | 2025-02-10 | 331R Timely 49483-331 Aspirin 325mg Delayed Release Tablets |
| 49483-331-01 | 2025-02-10 | 331R Timely 49483-331 Aspirin 325mg Delayed Release Tablets |
| 49483-331-10 | 2025-02-10 | 331R Timely 49483-331 Aspirin 325mg Delayed Release Tablets |
| 49483-331-00 | 2025-01-30 | 331R Timely 49483-331 Aspirin 325mg Delayed Release Tablets |
| 49483-331-01 | 2025-01-30 | 331R Timely 49483-331 Aspirin 325mg Delayed Release Tablets |
| 49483-331-10 | 2025-01-30 | 331R Timely 49483-331 Aspirin 325mg Delayed Release Tablets |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49483-331-00 | Enteric Coated AspirinRegular Strength | 100000 in 1 CARTON | TABLET, DELAYED RELEASE | 100000 | 8 | |
| 49483-331-01 | Enteric Coated AspirinRegular Strength | 100 in 1 BOTTLE, PLASTIC | TABLET, DELAYED RELEASE | 100 | 8 | |
| 49483-331-10 | Enteric Coated AspirinRegular Strength | 1000 in 1 BOTTLE, PLASTIC | TABLET, DELAYED RELEASE | 1000 | 8 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49483-331-01 | EA - Each | 49483-331 | 4cadaf05-9066-48aa-9702-2f3912b10d1b | 1 | 2014-06-03 |
| 49483-331-10 | EA - Each | 49483-331 | e229c0f3-6ea0-40b7-82ac-3e47bb1ccbf0 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PANADOL Extra | ACETAMINOPHEN AND CAFFEINE | Haleon US Holdings LLC | e5c2d88a-d903-4ca0-b895-f27e791dfc4e | 2024-02-06 | Warnings | M013 |
| PANADOL Extra Strength | ACETAMINOPHEN | Haleon US Holdings LLC | b2fe7f47-1a2e-40ee-8f8f-38f2028dce1b | 2024-02-06 | Warnings | M013 |
| PANADOL Extra Strength | ACETAMINOPHEN | Haleon US Holdings LLC | 9d384e88-5c11-4600-ac6c-a38371570138 | 2024-02-06 | Warnings | M013 |
| PANADOL | ACETAMINOPHEN | Haleon US Holdings LLC | 95801755-db54-4ad7-bec1-52671914f6ca | 2024-02-06 | Warnings | M013 |
| PANADOL PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Haleon US Holdings LLC | 01e7dddb-755c-4745-b701-edcdb6209064 | 2024-02-06 | Warnings, Adverse reactions | M013 |
| PANADOL PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Haleon US Holdings LLC | fe7cd1f2-9b00-4ded-99c2-8a152c71093c | 2024-02-06 | Warnings, Adverse reactions | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | AptaPharma Inc. | 9064943f-836f-4853-b6f2-2c4879941eeb | 2024-02-02 | Warnings | M013 |
| Quality Choice Effervescent Pain Relief | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 079af5d7-1be8-2a93-e063-6294a90a496d | 2024-02-01 | Warnings | M013 |
| MEDI-FIRST Non-Aspirin | ACETAMINOPHEN | Proficient Rx LP | 4c84948d-3a95-4c53-8529-7e7b9d8bb6df | 2024-02-01 | Warnings | M013 |
| Pharbetol | ACETAMINOPHEN | Proficient Rx LP | 9c7d65e4-df2f-47c1-a185-66aaf19aad2b | 2024-02-01 | Warnings | M013 |
| Childrens Acetaminophen | ACETAMINOPHEN | Proficient Rx LP | 57e4820c-b4eb-442e-9c49-93eedfbc5e5e | 2024-02-01 | Warnings | M013 |
| good sense aspirin | ASPIRIN | Proficient Rx LP | 73013074-9c6e-43c7-acde-4d9d8ed0133d | 2024-02-01 | Warnings | M013 |
| MEDIQUE APAP Extra Strength | ACETAMINOPHEN | Proficient Rx LP | c466a07f-2339-4cf5-8377-e0f109649c52 | 2024-02-01 | Warnings | M013 |
| Percogesic Extra Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE | Medtech Products Inc. | 2c5f1140-fb83-42c9-b0b1-5e2bd69340bb | 2024-02-01 | Warnings | M013 |
| aspirin | ASPIRIN | Proficient Rx LP | 3c7783a7-2b28-4968-b766-0a49dc70ce6d | 2024-02-01 | Warnings | M013 |
| Regular Strength Pain Relief | ACETAMINOPHEN | NuCare Pharmaceuticals,Inc. | 102bdcde-cb90-f248-e063-6394a90aac79 | 2024-01-30 | Warnings | M013 |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | Haleon US Holdings LLC | 61802b27-c9ec-4386-9d44-45e8b1e558b7 | 2024-01-28 | Warnings | M013 |
| AGRIFEN | ACETAMINOPHEN, ASPIRIN, CAFFEINE | OPMX LLC | 0fde22da-cdfc-36cc-e063-6294a90a3885 | 2024-01-26 | Warnings | M013 |
| DOLODOL | ACETAMINOPHEN, ASPIRIN, CAFFEINE | OPMX LLC | e80536f1-92cc-5bb3-e053-2995a90a9540 | 2024-01-26 | Warnings | M013 |
| LOW DOSE ASPIRIN | ASPIRIN | Bryant Ranch Prepack | d913d11f-c7a1-49d2-a2d3-9a29fc032806 | 2024-01-18 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198467 | aspirin 325 MG Delayed Release Oral Tablet | PSN | 5fbd8bb3-46f9-4089-9a21-b6af97a06106 | 8 |
| 198467 | aspirin 325 MG Delayed Release Oral Tablet | PSN | fd256c4a-a176-45dc-b757-fc01eb105008 | 8 |
| 198467 | aspirin 325 MG Delayed Release Oral Tablet | SCD | 5fbd8bb3-46f9-4089-9a21-b6af97a06106 | 8 |
| 198467 | aspirin 325 MG Delayed Release Oral Tablet | SCD | fd256c4a-a176-45dc-b757-fc01eb105008 | 8 |
| 198467 | ASA 325 MG Delayed Release Oral Tablet | SY | 5fbd8bb3-46f9-4089-9a21-b6af97a06106 | 8 |
| 198467 | ASA 325 MG Delayed Release Oral Tablet | SY | fd256c4a-a176-45dc-b757-fc01eb105008 | 8 |
| 198467 | aspirin 325 MG Enteric Coated Oral Tablet | SY | 5fbd8bb3-46f9-4089-9a21-b6af97a06106 | 8 |
| 198467 | aspirin 325 MG Enteric Coated Oral Tablet | SY | fd256c4a-a176-45dc-b757-fc01eb105008 | 8 |
| 198467 | aspirin 325 MG Delayed Release Oral Tablet | PSN | e05140fa-9766-4f97-bffc-e36a01b9d38f | 7 |
| 198467 | aspirin 325 MG Delayed Release Oral Tablet | SCD | e05140fa-9766-4f97-bffc-e36a01b9d38f | 7 |
| 198467 | ASA 325 MG Delayed Release Oral Tablet | SY | e05140fa-9766-4f97-bffc-e36a01b9d38f | 7 |
| 198467 | aspirin 325 MG Enteric Coated Oral Tablet | SY | e05140fa-9766-4f97-bffc-e36a01b9d38f | 7 |
| 198467 | aspirin 325 MG Delayed Release Oral Tablet | PSN | 51b11ee1-f881-4e12-8298-6994414ce0f7 | 6 |
| 198467 | aspirin 325 MG Delayed Release Oral Tablet | SCD | 51b11ee1-f881-4e12-8298-6994414ce0f7 | 6 |
| 198467 | ASA 325 MG Delayed Release Oral Tablet | SY | 51b11ee1-f881-4e12-8298-6994414ce0f7 | 6 |
| 198467 | aspirin 325 MG Enteric Coated Oral Tablet | SY | 51b11ee1-f881-4e12-8298-6994414ce0f7 | 6 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 49483-331-00 | 49483033100 | 100000 TABLET, DELAYED RELEASE in 1 CARTON (49483-331-00) | 2011-04-10 | 0000-00-00 | No | No | Current |
| 49483-331-01 | 49483033101 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (49483-331-01) | 2011-04-10 | 0000-00-00 | No | No | Current |
| 49483-331-10 | 49483033110 | 1000 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (49483-331-10) | 2011-04-10 | 0000-00-00 | No | No | Current |